Floxuridine
Floxuridine 是目前在国外临床研究中出现的一款新药或疗法，主要研究方向为Metastatic Colorectal Carcinoma、Metastatic Malignant Neoplasm in the Liver、Stage IV Colorectal Cancer AJCC v8、Unresectable Colorectal Carcinoma。下面汇总了它当前在全球正在招募患者的研究，以及中国患者可以走的申请途径。
10 项
全球在招研究
2 项
已进入 III/IV 期
5 个
开展国家和地区
有
中国境内设点
药品与企业信息
研发企业
- ECOG-ACRIN Cancer Research Group
- Michael J Cavnar, MD
- Peking Union Medical College Hospital
- The Netherlands Cancer Institute
- AdventHealth
- Erasmus Medical Center
- National Cancer Institute (NCI)
- Memorial Sloan Kettering Cancer Center
汇总自相关试验登记的主要申办方；研究机构申办时会显示相应机构名称。
生产企业
公开药品批准资料或正式说明书暂未提供明确的生产企业信息。
研发企业与生产企业可能不是同一家。研究阶段药品可能尚未公布生产企业；生产企业仅取自美国上市原研药说明书所列企业（不含仿制药），不作推测；仅在其他国家上市的药品暂无法显示。
主要开展国家和地区
美国、中国、荷兰、加拿大、挪威
正在招募患者的 Floxuridine 研究
Study of Safety/Feasibility of a Hybrid Model of Tertiary and Community Delivery of Hepatic Artery Infusion Chemotherapy
II 期招募中美国NCT07201519Camrelizumab Plus Apatinib in Patients With High-risk Gestational Trophoblastic Neoplasia
II 期招募中中国NCT05139095Induction Treatment for Initially Unresectable Colorectal Liver Metastases: Combined Hepatic Arterial Infusion Pump Therapy With Systemic Therapy
III 期招募中荷兰NCT06857773Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial
III 期招募中美国NCT05863195Hepatic Artery Infusion Pump Chemotherapy for Liver Metastases From Resected Pancreatic and Duodenal Adenocarcinoma
不适用招募中美国NCT07845617Additional Chemotherapy Administered Directly Into the Liver Using a Chemo Pump in Patients With Bile Duct Cancer Inside the Liver Treatable by Surgery
II 期招募中荷兰NCT06888063PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma
II 期招募中美国NCT05286814Gemcitabine and Oxaliplatin Chemotherapy With or Without a Floxuridine and Dexamethasone Pump in People With Cholangiocarcinoma That Cannot Be Removed With Surgery
II 期招募中美国荷兰NCT04891289Hepatic Arterial Infusion Chemotherapy in Patients With Inoperable Colorectal Cancer Liver Metastasis
II 期招募中加拿大NCT07764497HAI-Floxuridine, or SIRT, Combined With Gemox For Patients With Intra-Hepatic Cholangiocarcinoma Not Amenable to Resection (TOMCAT)
II 期招募中挪威NCT06313203
中国患者怎么争取用上这款药
这款药已经有研究在中国境内设点，可以先带完整病历去对应医院咨询入组；同时也可以并行了解下面几条途径，多一条备选。
查看完整申请指南同类方向的其他在研新药
本页信息整理自 ClinicalTrials.gov 公开登记数据，仅供参考，不构成医疗建议；是否适合使用该药物，请以专业医生和研究团队的意见为准。